奧飛數據(300738.SZ):擬出資1.38億元參與設立產業基金 投資新能源、節能減排等領域未上市企業
格隆匯 11 月 13日丨奧飛數據(300738.SZ)公佈,公司擬出資1.38億元人民幣與北京復樸道和投資管理有限公司(以下簡稱“復樸道和”)、廊坊市藍天事業發展股權投資基金合夥企業(有限合夥)(以下簡稱“廊坊藍天基金”)共同發起設立廊坊市復樸奧飛協同股權投資基金合夥企業(有限合夥)(以在工商部門最終設立登記的名稱為準)。
投資方向:與數據中心產業相關的新能源、節能減排等領域未上市企業的投資。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.